Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis
R. Wootton et al., Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis, BR MED J, 320(7244), 2000, pp. 1252-1256
Citations number
13
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objectives Comparison of real time teledermatology with outpatient dermatol
ogy in terms of clinical outcomes, cost-benefits, and patient reattendance.
Design Randomised controlled trial with a minimum follow up of three months
.
Setting Four health centres (two urban, two rural) and two regional hospita
ls.
Subjects 204 general practice patients requiring referral to dermatology se
rvices; 102 were randomised to teledermatology consultation and. 102 to tra
ditional outpatient consultation.
Main outcome measures Reported clinical outcome of initial consultation, pr
imary care and outpatient reattendance data, and cost-benefit analysis of b
oth methods of delivering care.
Results No major differences were found in the reported clinical outcomes o
f teledermatology and conventional dermatology. Of patients randomised to t
eledermatology, 55 (54%) were managed within primary care and 47 (46%) requ
ired at least one hospital appointment. Of patients randomised to the conve
ntional hospital outpatient consultation, 46 (45%) required at least one fu
rther hospital appointment, 15 (15%) required general practice review and 3
0 (39%) no follow up visits. Clinical records showed that 42 (41%) patients
seen by teledermatology attended subsequent hospital appointments compared
with 41 (40%) patients seen conventionally. The net societal cost of the i
nitial consultation was pound 132.10 pet patient for teledermatology and po
und 48.73 for conventional consultation. Sensitivity analysis revealed that
if each health centre had allocated one morning session a week to telederm
atology and the average round trip to hospital had been 78 km instead of 26
km, the costs of the two methods of care would have been equal.
Conclusions Real time teledermatology was clinically feasible but not cost
effective compared with conventional dermatological outpatient care. Howeve
r, if the equipment were purchased at current prices and the travelling dis
tances greater, teledermatology would be a cost effective alternative to co
nventional care.